SEARCH

SEARCH BY CITATION

References

  • 1
    Federal Register. [FR Doc. 98–8191] 42 CFR Part 121, April 2, 1998:16296.
  • 2
    Components of the CTP score employed in the previous liver allocation policy. Available at: www.unos.org. Accessed July 31, 2002.
  • 3
    Committee on Organ Procurement and Transplantation Policy. Organ Procurement and Transplantation: Assessing Current Policies and the Potential Impact of the DHHS Final Rule. Washington, DC: National Academy Press, 1999:82.
  • 4
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter-Borg PL. A model to predict poor survival in patients undergoing Transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864871.
  • 5
    Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001; 7:567580.
  • 6
    SPLIT Research Group. Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes. Transplantation 2001; 72:463476.
  • 7
    Yao FY, Bass NM, Watson J, Davern T, Wu V, Moore B, et al. Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat, and the rate of “dropout” from the waiting list. Hepatology 2001; 34:174A.
  • 8
    Lovelet JM, Foster J, Briux J. Intention-to-treat analysis of surgical treatment of early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999; 30:14341440.
  • 9
    Lovelet JM, Briux J, Gores GJ. Surgical resection versus transplantation for early hepatocellular carcinoma: Clues for the best strategy. Hepatology 2000; 31:10191021.
  • 10
    Manjo PE, Sarasin FP, Mentha G, Hedengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome oriented decision analysis. Hepatology 2000; 31:899906.
  • 11
    Cheng SJ, Freeman, RB, Wong JB. Predicting the probability of progression free survival in patients with small hepatocellular carcinoma. Liver Transpl 2002; 8:323328.
  • 12
    Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:2936.
  • 13
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end stage liver disease. Hepatology 2001; 33:464470.
  • 14
    Garrett KO, Reilly JJ, Schade RR, van Theil DW. Sclerotherapy of esophageal varices: Long term results and determinants of survival. Surgery 1988; 104:813818.
  • 15
    DiMango EP, Zinsmeister AR, Larson DE, Viggiano TR, Clain JE, Laughlin BL, et al. Influence of hepatic reserve and cause of esophageal varices on survival and rebleeding before and after the introduction of sclerotherapy: A retrospective analysis. Mayo Clin Proc 1985; 60:149157.
  • 16
    Milliken WJ, Warren DW, Henderson JM, Smith RB, Salam AA, Galambos JT, et al. The Emory prospective randomized trial: Selective versus nonselective shunt to control variceal bleeding: Ten year follow-up. Ann Surg 1985;201:712722.
  • 17
    Wolfe R, Merion R, Dykstra D, Rasmussen C. Analysis for Data Request from the OPTN Liver and Intestinal Committee of 08/01/01. Scientific Registry of Transplant Recipients. Available at: www.ustransplant.org. Accessed July 31, 2002.
  • 18
    Bennett-Guerrero E, Feierman DE, Barclay GR, Parides MK, Sheiner PA, Mythen MG, et al. Preoperative and intraoperative predictors of postoperative morbidity, poor graft function, and early rejection in 190 patients undergoing liver transplantation. Arch Surg 2001; 136:11771183.
  • 19
    Gayowski T, Marino IR, Singh N, Doyle H, Wagener M, Fung JJ, Starzl TE. Orthotopic liver transplantation in high-risk patients: Risk factors associated with mortality and infectious morbidity. Transplantation 1998; 65:499504.
  • 20
    Wolfe R, Merion R, Dykstra D, Rasmussen C. Analysis for Data Request from the OPTN Liver and Intestinal Committee of 08/01/01 Final Report. Scientific Registry of Transplant Recipients. Available at: www.ustransplant.org. Accessed July 31, 2002.
  • 21
    Wolfe R, Merion R, Dykstra D, Rasmussen C. Analysis for Data Request from the OPTN Liver and Intestinal Committee of 10/10/01 Final Report. Scientific Registry of Transplant Recipients. Available at: www.ustransplant.org. Accessed July 31, 2002.
  • 22
    Krowka MJ. Hepatopulmonary syndrome: recent literature (1997 to 1999) and implications for liver transplantation. Liver Transpl 2000; 6(suppl 1):S3135.
  • 23
    Krowka MJ, Porayko MK, Plevak DJ, Pappas SC, Steers JL, Krom RAF, Wiesner RH. Hepatopulmonary syndrome with progressive hypoxemia is an indication for liver transplant. Mayo Clin Rev 1997; 72:4453.
  • 24
    Freeman RB, Rohrer RJ, Katz E, Lewis WD, Jenkins RL, Cosimi AB, et al. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl 2001; 7:173178.
  • 25
    Freeman RB, Harper A, Edwards EB. There is minimal variation among UNOS regions in prospectively collected MELD scores for patients receiving liver transplants. Am J Transpl 2002, 2:251S.